GTC Biotherapeutics 2008 PRESS RELEASE ARCHIVE


	2008 PRESS RELEASE ARCHIVE November 11, 2008 - GTC Biotherapeutics Receives NASDAQ Notice November 5, 2008 - GTC Biotherapeutics to Webcast Corporate Presentation at the Rodman & Renshaw 10th Annual Healthcare Conference November 3, 2008 - GTC Biotherapeutics Reports Third Quarter 2008 Financial Results November 3, 2008 - GTC Signs Agreement for $15 Million Convertible Debt Financing From LFB - Financing Subject to Shareholder Approval October 29, 2008 - GTC Biotherapeutics to Announce Third Quarter 2008 Earnings on Monday, November 3, 2008 October 6, 2008 - FDA Accepts ATryn® BLA Filing - GTC Receives $2 Million in Additional Milestone Payments September 4, 2008 - FDA Assigns Priority Review to GTC Biotherapeutics’ATryn® August 14, 2008 - GTC Biotherapeutics and Ovation Pharmaceuticals Close Agreement to Market and Develop ATryn® in the U.S. August 7, 2008 - GTC Biotherapeutics Completes BLA Submission for Atryn® August 7, 2008 - GTC Biotherapeutics Reports Second Quarter 2008 Financial Results July 31, 2008 - GTC Biotherapeutics to Announce Second Quarter 2008 Earnings on Thursday, August 7th, 2008 July 25, 2008 - GTC Biotherapeutics to Transfer to NASDAQ Capital Market July 18, 2008 - GTC Biotherapeutics Receives NASDAQ Notice of Non-Compliance July 7, 2008 - GTC Biotherapeutics to Webcast Corporate Presentation at the Collins Stewart Fourth Annual Growth Conference July 2, 2008 - GTC Biotherapeutics Receives Notice Related to NASDAQ Minimum Market Value Rule June 25, 2008 - GTC Biotherapeutics Licenses Recombinant Fibrinogen Patents to Pharming June 23, 2008 - GTC Biotherapeutics Enters into $257 Million Agreement with OVATION Pharmaceuticals to Develop and Market ATryn® in the U.S. May 13, 2008 - GTC Biotherapeutics to Webcast Corporate Presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference May 8, 2008 - GTC Biotherapeutics Reports First Quarter 2008 Financial Results May 8, 2008 - LFB Biotechnologies and GTC Biotherapeutics to Collaborate on rhAAT Program May 1, 2008 - GTC Biotherapeutics to Host First Quarter 2008 Earnings Call and Webcast on Thursday May 8, 2008 March 27, 2008 - GTC Biotherapeutics and Pharmathene Extend Agreement for Protexia® Program March 6, 2008 - GTC Biotherapeutics Reports Fourth Quarter and Year End 2007 Financial Results February 28, 2008 - GTC Biotherapeutics to Host Fourth Quarter and Year End 2007 Earnings Call and Webcast on Thursday, March 6, 2008 February 25, 2008 - Last Patient Enrolled in ATryn® Pivotal Study February 8, 2008 - GTC Biotherapeutics to Raise $6 Million in Registered Direct Offering February 6, 2008 - GTC Biotherapeutics to Webcast Corporate Presentation at the 10th Annual BIO CEO & Investor Conference February 4, 2008 - ATryn® Meets Primary Endpoint/Rolling BLA Submission Initiated January 18, 2008 - GTC Biotherapeutics Receives Notice Related to NASDAQ Minimum Closing Bid Price Rule January 10, 2008 - LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program January 7, 2008 - ATryn® Nears Completion of US HD Clinical Study
	Copyright 2008 GTC Biotherapeutics, All Rights Reserved